Cardlytics Chief Legal & Privacy Officer Nick Lynton to resign; receives $380K+ severance

Cardlytics, Inc.

Nick Lynton resigns as Chief Legal & Privacy Officer, effective July 3, 2026 or upon successor appointment.
Lynton will remain in a non-officer advisory role until Effective Date to transition responsibilities.
Separation includes a $380,000 lump sum payment plus COBRA reimbursement for up to 12 months.
Additional $70,320.21 lump sum payment expected in Q1 2027.
Transition Agreement replaces prior Separation Pay Agreement dated August 8, 2022.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Nick Lynton

Chief Legal and Privacy Officer

CDLX · Cardlytics, Inc.

Effective: 2026-07-03
Filed: May 12, 2026, 4:10 PM ET

On May 10, 2026, Nick Lynton, Chief Legal and Privacy Officer of Cardlytics, Inc. (the “Company”), notified the Company of his intent to resign from such position, effective as of the earlier of the appointment of his successor or the close of business on July 3, 2026 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nick Lynton departed as Chief Legal and Privacy Officer at Cardlytics, Inc..

Action: resign
Role: Chief Legal and Privacy Officer

Exact text from the filing

On May 10, 2026, Nick Lynton, Chief Legal and Privacy Officer of Cardlytics, Inc. (the “Company”), notified the Company of his intent to resign from such position, effective as of the earlier of the appointment of his successor or the close of business on July 3, 2026 (the “Effective Date”).

View on SEC.gov

Cardlytics, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-034107

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.